Hypoglycemia

Hypoglycemia is blood sugar dropping too low. It’s an important term for anyone on a GLP-1, though the risk depends heavily on what else you take.

Why GLP-1s rarely cause it alone

GLP-1 medications stimulate insulin in a glucose-dependent way — the “glucose-dependent” part of GIP’s name captures the general principle. In plain terms: they nudge insulin release mainly when blood sugar is high, and ease off when it’s normal or low. That built-in brake is why, on their own, GLP-1s carry a low risk of hypoglycemia. Someone taking only semaglutide for weight management, without diabetes medications, is unlikely to go hypo from the drug itself.

Where the real risk is: combinations

The picture changes with other glucose-lowering drugs. Combined with insulin or sulfonylureas (like glipizide or glimepiride), GLP-1s meaningfully raise hypoglycemia risk — the effects stack. This is why prescribers often reduce those medications when starting a GLP-1, and why it matters that every clinician who treats you knows you’re on one.

Know the symptoms

Shakiness, sweating, sudden intense hunger, dizziness, confusion, irritability, a racing heart. The standard response is the “15-15 rule”: 15 grams of fast carbohydrate (glucose tablets, juice), wait 15 minutes, recheck. If you’re on insulin or a sulfonylurea alongside your GLP-1, this is worth an explicit plan with your prescriber — including whether you should be monitoring your blood sugar.